Corporate law

SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, OBLN, FI, and BMTC Shareholders About Its Ongoing Investigations

Friday, April 16, 2021 - 9:15pm

b'WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Newtown Lane Marketing, Inc. (OTC: NTWN) in connection with the company\'s proposed merger with Appgate.Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.If you own NTWN shares and wish to discuss this investigation or your rights, please call or visit our website: https://weisslawllp.com/news/ntwn/\nWeissLaw LLPis investigating possible breachesof fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (NASDAQ: OBLN) in connection with the proposed merger of the company with ReShape Lifesciences Inc. ("ReShape").Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc.If you own OBLN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/obln/\nWeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Frank\'s International N.V. (NYSE: FI) in connection withthe proposed acquisition of the company by Expro Group ("Expro").Under the terms of the merger agreement, Expro shareholders will receive 7.272 FI shares per Expro share they own.Upon consummation of the transaction, FI shareholders will only own approximately 35% of the combined entity, with Expro shareholders owning approximately 65%.

Key Points: 
  • b'WeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Newtown Lane Marketing, Inc. (OTC: NTWN) in connection with the company\'s proposed merger with Appgate.Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.If you own NTWN shares and wish to discuss this investigation or your rights, please call or visit our website: https://weisslawllp.com/news/ntwn/\nWeissLaw LLPis investigating possible breachesof fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (NASDAQ: OBLN) in connection with the proposed merger of the company with ReShape Lifesciences Inc. ("ReShape").Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc.If you own OBLN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/obln/\nWeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Frank\'s International N.V. (NYSE: FI) in connection withthe proposed acquisition of the company by Expro Group ("Expro").Under the terms of the merger agreement, Expro shareholders will receive 7.272 FI shares per Expro share they own.Upon consummation of the transaction, FI shareholders will only own approximately 35% of the combined entity, with Expro shareholders owning approximately 65%.
  • If you own FI shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/fi/\nBryn Mawr Bank Corporation (NASDAQ: BMTC)\nWeissLaw LLPis investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Bryn Mawr Bank Corporation (NASDAQ: BMTC) in connection withthe proposed acquisition of the company by WSFS Financial Corporation ("WSFS").Under the terms of the merger agreement, BMTC shareholders will receive 0.90 shares of WSFS common stock for each BMTC share that they own, representing implied per-share merger consideration of $44.93 based upon WSFS\' April 15, 2021 closing price of $49.92.
  • If you own BMTC shares and wish to discuss this investigation or your rights, please call us or visit our website: http://www.weisslawllp.com/bmtc\nView original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-r...\n'

Report from the annual general meeting in OXE Marine AB (publ) on 16 April 2021

Friday, April 16, 2021 - 11:20am

b"The annual general meeting resolved, among other things, the following:\nThe income statement and balance sheet for 2020 were adopted.

Key Points: 
  • b"The annual general meeting resolved, among other things, the following:\nThe income statement and balance sheet for 2020 were adopted.
  • The board shall have the right to resolve on rights issues as well as issues with deviation from the shareholders' pre-emption rights.
  • Each warrant entitles to subscription of one new share in OXE at the subscription price of SEK 6 per share.
  • The complete proposals are published on the company's website www.oxemarine.com .\nContact details to FNCA Sweden AB: tel.+46 8 528 00399,e-mail info@fnca.se\n"

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Corning Natural Gas Holding Corp. - CNIG

Saturday, April 10, 2021 - 2:00am

Under the terms of the agreement, CNIG shareholders will receive $24.75 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, CNIG shareholders will receive $24.75 in cash per share they own.
  • The investigation focuses on whether Corning Natural Gas Holding Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
  • Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
  • If you own common stock in Corning Natural Gas Holding Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq.

POCML 5 Inc. Announces Approval of Meeting Matters and Changes Pursuant to New CPC Policy

Friday, April 9, 2021 - 7:14pm

All matters submitted to shareholders of the Company for approval at the Meeting are more particularly described in the Company's management information circulated dated March 12, 2021 (the "Circular").

Key Points: 
  • All matters submitted to shareholders of the Company for approval at the Meeting are more particularly described in the Company's management information circulated dated March 12, 2021 (the "Circular").
  • Please refer to the Circular for further details with respect to the amendments associated with the New CPC Policy.
  • The Company is a CPC within the meaning of the policies of the TSXV that has not commenced commercial operations and has no assets other than cash.
  • Forward-looking information includes, but is not limited to, the approval of disinterested shareholders of matters under the New CPC Policy at the general and special shareholder meeting and the future business of the Company.

ISS Recommends Blucora Stockholders Vote For Boardroom Change on Ancora’s WHITE Proxy Card

Friday, April 9, 2021 - 7:20pm

In its report, ISS has endorsed Ancoras case for boardroom change, recommended for the election of wealth management expert and stockholder representative Fredrick D. DiSanto, and only recommends re-electing six current, unopposed members of the Board of Directors (the Board).

Key Points: 
  • In its report, ISS has endorsed Ancoras case for boardroom change, recommended for the election of wealth management expert and stockholder representative Fredrick D. DiSanto, and only recommends re-electing six current, unopposed members of the Board of Directors (the Board).
  • Ancora urges Blucoras stockholders to visit www.ABetterBlucora.com to obtain important information, including instructions for how to vote on the WHITE Proxy Card.
  • The merits of the issues raised by the dissident lead to a conclusion that change is warranted, specifically in the form of direct shareholder representation in the boardroom.
  • Mr. DiSanto, Ancoras Chairman and Chief Executive Officer, commented:
    Ancora is pleased that ISS is recommending stockholders vote on the white card to facilitate sorely-needed change in Blucoras boardroom.

9 Capital Corp. Announces Approval of Meeting Matters and Changes Pursuant to New CPC Policy

Friday, April 9, 2021 - 3:29pm

All matters submitted to shareholders of the Company for approval at the Meeting are more particularly described in the Company's management information circulated dated March 11, 2021 (the "Circular").

Key Points: 
  • All matters submitted to shareholders of the Company for approval at the Meeting are more particularly described in the Company's management information circulated dated March 11, 2021 (the "Circular").
  • Please refer to the Circular for further details with respect to the amendments associated with the New CPC Policy.
  • The Company is a CPC within the meaning of the policies of the TSXV that has not commenced commercial operations and has no assets other than cash.
  • Forward-looking information includes, but is not limited to, the approval of disinterested shareholders of matters under the New CPC Policy at the general and special shareholder meeting and the future business of the Company.

Blucora Shareholder Sends Open Letter in Support Of Incumbent Directors

Friday, April 9, 2021 - 1:00pm

LOS ANGELES, April 09, 2021 (GLOBE NEWSWIRE) -- Jonathan Foster, President and CEO of Angeles Wealth Management, LLC, and a personal shareholder of Blucora, Inc., today issued an open letter expressing support for the incumbent Board of Directors at the upcoming 2021 annual meeting of stockholders, scheduled to be held on April 21, 2021.

Key Points: 
  • LOS ANGELES, April 09, 2021 (GLOBE NEWSWIRE) -- Jonathan Foster, President and CEO of Angeles Wealth Management, LLC, and a personal shareholder of Blucora, Inc., today issued an open letter expressing support for the incumbent Board of Directors at the upcoming 2021 annual meeting of stockholders, scheduled to be held on April 21, 2021.
  • Full text of the letter follows:
    Dear Fellow Shareholders of Blucora:
    In watching the proxy fight process unfold and reading the dialogue from both sides, I feel compelled to make my opinion known as a fellow personal shareholder.
  • Angeles Wealth Management, and its affiliate Angeles Investment Advisors, do not hold any interest in Blucora.
  • I have been a private client advisor and operator of advisory businesses for over 30 years.

Bionomics Successfully Completes A$22.9 million Equity Raise

Friday, April 9, 2021 - 11:00am

The Entitlement Offer closed at 5.00pm (Adelaide time) on 30 March 2021 and raised approximately A$20.4 million from the offer of approximately 140.9 million new fully paid ordinary shares in Bionomics (New Shares) at the offer price of A$0.145 per New Share.

Key Points: 
  • The Entitlement Offer closed at 5.00pm (Adelaide time) on 30 March 2021 and raised approximately A$20.4 million from the offer of approximately 140.9 million new fully paid ordinary shares in Bionomics (New Shares) at the offer price of A$0.145 per New Share.
  • Applications under the Oversubscription Facility were in excess of the approximately 55.3 million shares or A$8 million shortfall and were scaled back in accordance with the terms of the Entitlement Offer on a pro rata basis.
  • The Concurrent Placement which was made on substantially the same terms as the Entitlement Offer raised approximately A$2.5 million from the offer of approximately 17.2 million new fully paid ordinary shares in Bionomics (New Concurrent Shares) at the offer price of A$0.145 per New Concurrent Share.
  • The New Concurrent Shares issued under the Concurrent Placement were allocated from Bionomics' expanded placement capacity following the Entitlement Offer.

Kindred Group plc - AGM Notice

Friday, April 9, 2021 - 6:24am

The 2020 Annual Report was finalised and signed on 12 March 2021 and reflects events up to that date.

Key Points: 
  • The 2020 Annual Report was finalised and signed on 12 March 2021 and reflects events up to that date.
  • The Board of Directors proposes that the AGM approves the remuneration report on pages 49-52 of the Company's Annual Report and Financial Statements for the year ended 31 December 2020.
  • CVs for Directors are to be found on page 32-33 in the Kindred Group plc Annual Report for 2020 and on the Company's website.
  • Since 2010, Dr. Carlsson has been active in over twenty listed companies' nomination committees, including Kambi, Kindred and SKF.

Kindred Group plc - AGM Notice

Friday, April 9, 2021 - 6:16am

The 2020 Annual Report was finalised and signed on 12 March 2021 and reflects events up to that date.

Key Points: 
  • The 2020 Annual Report was finalised and signed on 12 March 2021 and reflects events up to that date.
  • The Board of Directors proposes that the AGM approves the remuneration report on pages 49-52 of the Company's Annual Report and Financial Statements for the year ended 31 December 2020.
  • CVs for Directors are to be found on page 32-33 in the Kindred Group plc Annual Report for 2020 and on the Company's website.
  • Since 2010, Dr. Carlsson has been active in over twenty listed companies' nomination committees, including Kambi, Kindred and SKF.